Inify Laboratories announces application periods for fully guaranteed private placement and fully guaranteed repair issue

Inify Laboratories has launched a fully guaranteed equity raise of roughly NOK 100 million via a NOK 92 million private placement (subscription price NOK 3.50, minimum subscription ≈ EUR 100,000 equivalent) open 9–16 Dec 2025 and a subsequent ~NOK 8 million repair issue for smaller existing shareholders (application ~12–26 Jan 2026); only existing shareholders may participate pro rata and those who subscribe can maintain their stake. Net proceeds are earmarked to shore up liquidity after a fit-out delay and higher-than-expected UK establishment investments; payment is expected around 25 Mar 2026 with shares deliverable and tradable on Euronext Growth Oslo by ~30 Mar 2026. The financing is fully underwritten (SB1 Markets adviser, Schjødt legal counsel), carries foreign-direct-investment notification considerations for large investors and is subject to standard cross‑jurisdictional distribution restrictions.

Analysis

Inify Laboratories announced a fully guaranteed equity raise totaling approximately NOK 100 million, split into a NOK 92 million private placement directed pro rata to existing shareholders holding more than 1,000,000 shares (minimum subscription ~EUR 100,000 equivalent) and a subsequent ~NOK 8 million repair issue for smaller shareholders. The subscription price is NOK 3.50 per share; the Private Placement application window is 9–16 December 2025 and the Repair Issue application window is scheduled for about 12–26 January 2026.

The company states net proceeds will shore up financial stability after a slight delay in a fit-out project and larger-than-expected investments related to establishing operations in the UK, implying near-term cash needs rather than opportunistic expansion financing. Settlement is expected around 25 March 2026 with new shares deliverable and tradable by ~30 March 2026; the offering is fully underwritten and advised by SB1 Markets with Schjødt as legal counsel, which reduces execution risk.

Regulatory and structural considerations include potential notification requirements under Sweden’s FDI Act for investors crossing voting thresholds and distribution restrictions across multiple jurisdictions (notably the United States and several other markets). Market signals flag mixed sentiment and a modest market-impact score, reflecting dilution risk and conditional confidence in management’s rationale for the raise.

Key Decisions for Investors

• Large existing shareholders (>1,000,000 shares) should consider participating pro rata in the Private Placement at NOK 3.50 to avoid dilution, subject to meeting the ~EUR 100,000 minimum subscription and assessing any FDI notification implications
• Smaller shareholders should prepare to apply in the Repair Issue (anticipated 12–26 Jan 2026) to maintain pro rata ownership and check whether their shares are registered in VPS or Euroclear to determine entitlement to subscription rights
• Non-participating holders should consider reducing exposure or hedging before new shares are issued (payment ~25 Mar 2026, tradability ~30 Mar 2026) because the raise signals near-term funding needs and potential dilution
• Any investor planning a large stake must consult legal counsel on the FDI Act thresholds and jurisdictional distribution restrictions prior to investment, and monitor company disclosures on the use of proceeds and progress on the UK establishment